A biotechnology company is a company whose products or services primarily use biotechnology methods for their production, design or delivery. The United Nations Convention on Biological Diversity defines 'biotechnology' as: "Any technological application that uses biological systems, living organisms, or derivatives thereof, to make or modify products or processes for specific use." In other words, biotechnology can be defined as the mere application of technical advances in life science to develop commercial products. Today, no comprehensive global database of biotech companies is available online, despite the fact that a free and open access project was launched in late 2014.
TOP 25 BIOTECH COMPANIES AROUND THE WORLD ALONG WITH THEIR STATISTICS:
| Rank | Change | Company | Country | Highest Market Cap ever (historical)(USD billions) | Market Cap in Q1 2016(USD billions)[3][4] | Market Cap in 2015(USD billions)[5] | Market Cap in 2014(USD billions)[6] | Market Cap in 2013(USD billions) |
|---|---|---|---|---|---|---|---|---|
| 1 |  | Johnson & Johnson |  United States | 306.4 September 2014 | 298.9 | 284.2 | 277.8 | 258.3 |
| 2 | | Roche |  Switzerland | 263.6 February 2014 | 208.8 | 234.7 | 258.5 | 240.3 |
| 3 | | Novartis | Switzerland | 275.2 July 2015 | 195.2 | 206.1 | 229.8 | 195.0 |
| 4 | | Pfizer | United States | 310.5 July 2000 | 186.4 | 199.3 | 205.4 | 196.0 |
| 5 |  | Merck & Co. | United States | 178.9 January 2015 | 148.0 | 147.6 | 166.9 | 146.5 |
| 6 | | Gilead Sciences | United States | 179.6 June 2013 | 124.9 | 145.8 | 109.0 | 78.4 |
| 7 | | Amgen | United States | 130.6 December 2014 | 113.3 | 122.5 | 93.1 | 78.7 |
| 8 |  | Novo Nordisk |  Denmark | 153.8 June 2015 | 112.0 | 153.9 | 125.4 | 19.6 |
| 9 | | Sanofi |  France | 151.3 September 2014 | 106.6 | 111.8 | 138.1 | 142.0 |
| 10 | | Bristol-Myers Squibb | United States | 115.3 May 2015 | 105.4 | 114.8 | 97.6 | 87.2 |
| 11 | | GlaxoSmithKline |  United Kingdom | 174.9 May 2006 | 100.2 | 97.6 | 128.9 | 129.6 |
| 12 | | Bayer |  Germany | 129 March 2015 | 97.1 | 103.2 | 113.2 | 117.4 |
| 13 | | AbbVie | United States | 112.2 June 2015 | 92.5 | 96.8 | 104.1 | 83.8 |
| 14 | | Eli Lilly & Co | United States | 122.6 August 2000 | 79.7 | 93.4 | 76.6 | 57.0 |
| 15 | | Celgene | United States | 102.9 March 2015 | 77.6 | 94.1 | 89.5 | 69.2 |
| 16 | | AstraZeneca | United Kingdom | 102.9 October 2006 | 70.9 | 85.8 | 88.9 | 74.6 |
| 17 | | Abbott Laboratories | United States | 74.8 July 2015 | 62.0 | 67.0 | 67.9 | 59.3 |
| 18 | | Biogen Idec | United States | 111.7 March 2015 | 56.6 | 68.3 | 79.7 | 66.1 |
| 19 | | Teva Pharmaceutical |  Israel | 58.9 April 2010 | 54.1 | 55.9 | 49.0 | 37.8 |
| 20 | | Stryker Corporation | United States | 40.2 March 2016 | 40.2 | 34.7 | 35.7 | 28.4 |
| 21 | | Regeneron Pharmaceuticals Inc | United States | 56.5 December 2015 | 37.3 | 56.5 | 42.0 | 27.4 |
| 22 | | Shire Pharmaceuticals |  Ireland | 52.4 October 2014 | 34.0 | 41.0 | 42.4 | 28.1 |
| 23 | | Alexion Pharmaceuticals | United States | 43.1 June 2015 | 31.6 | 43.0 | 36.8 | 26.2 |
| 24 | | Baxalta Inc | United States | 27.5 April 2015 | 27.5 | 27.5 | 21.2 | 16.1 |
| 25 | | Mylan | United States | 37.2 April 2015 | 22.8 | 26.6 | 21.2 | 16.1 |
No comments:
Post a Comment